Back to search

Article

Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapy

2026-06-14

Abstract excerpt

<title>Abstract</title> <p> Background Peptide receptor radionuclide therapy with [ <sup>177</sup> Lu]Lu-DOTATATE is an established treatment for somatostatin receptor–expressing neuroendocrine tumors. Although strong anti-tumor effects have been demonstrated in experimental models, curative responses in patients remain limited. Improved understanding of the molecular responses induced by [ <sup>177</sup> L...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0259ed0a-5a7e-51b4-aa3e-b60da777e2ca
DOI
10.21203/rs.3.rs-9833935/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapyDOI 10.21203/rs.3.rs-9833935/v1
Select a neighboring publication to make it the new centre.